CNE100003P25
CNE100003P25
QINGDAO HAIER BIOMEDICAL CO LTD
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 |
|---|---|---|---|
Market & Enterprise Value | |||
Market Cap | 11.12B EUR | 8.36B EUR | 9.88B EUR |
Enterprise Value | 9.71B EUR | 7.46B EUR | 9B EUR |
Valuation Multiples | |||
Trailing P/E | 42.84x | 36.01x | 35.98x |
Forward P/E | 18.39x | -- | -- |
Price to Sales | 4.58x | 3.53x | 4.09x |
Price to Book | 2.49x | 1.89x | 2.22x |
EV/Revenue | 4x | 3.15x | 3.73x |
EV/EBITDA | 30.67x | 29.28x | 27.85x |
Price to FCF (P/FCF) | 48.42x | 39.17x | 89.63x |
EV/FCF | 42.3x | 34.93x | 81.66x |
FCF Yield | 2.07% | 2.55% | 1.12% |